Skip to content
Parker Institute for Cancer Immunotherapy
Search Close

PICI Network Researchers to Present at #KSCancerImmuno23

Six investigators from the Parker Institute for Cancer Immunotherapy (PICI) Network will discuss progress in immunotherapeutic interventions, at the Keystone Symposia conference, “Cancer Immunotherapy: Mechanisms of Response Versus Resistance,” March 5-9 in Banff, Alberta.

The researchers will analyze challenges and advances in improving efficacy for patients who do not respond to immune checkpoint blockade, vaccination against tumor antigens or other treatments that have benefited some patients.

PICI Network member Nina Bhardwaj, MD, PhD, of The Tisch Cancer Institute at Mount Sinai is one of three scientific organizers of the conference. She also will present March 7. On March 6, James P. Allison, PhD, of The University of Texas MD Anderson Cancer Center will deliver the conference welcome and keynote address.

Below are the sessions featuring PICI Network investigators. Please note that all events listed are subject to change. For the most current information, visit the conference program (pdf). Keystone Symposia will make some programming available on-demand. Follow the meeting live on Twitter using the hashtag #KSCancerImmuno23.

March 6

Welcome and Keynote Address: Checkpoint Blockade: Where Do We Go from Here?
Presenter: James P. Allison, PhD (Twitter: @JimAllisonPhD)

March 7

Session: Vaccines

Presenter: Nina Bhardwaj, MD, PhD (Twitter: @BhardwajLab)
Presentation: Properties of Tumor Neoantigens Determining Induction of Immunity

Presenter: Catherine J. Wu, MD, Dana-Farber Cancer Institute
Presentation: Neoepitope Vaccines

Presenter: Robert D. Schreiber, PhD, Washington University School of Medicine in St. Louis
Presentation: Integrating CD4 and CD8 Epitopes

March 9

Session: Learning from the Patient: Reverse Translation

Presenter: Padmanee Sharma, MD, PhD, (Twitter: @PamSharmaMDPhD) The University of Texas MD Anderson Cancer
Presentation: Checkpoint Blockade Mechanisms of Response Versus Resistance 

Session: Engineered Immune Cell Strategies

Presenter: Philip D. Greenberg, MD, University of Washington and Fred Hutchinson Cancer Center
Presentation: Engineered T Cell Therapies for Solid Tumors